Dear colleagues,

The following Special Issue will be published in Journal of Personalized
Medicine (JPM, ISSN 2075-4426, http://www.mdpi.com/journal/jpm/),
and is now open to receive submissions of full research papers and
comprehensive review articles for peer-review and possible publication:

Special Issue: Untold Stories about Personalized Medicine: If You Thought
Personalized Medicine Is for Others to Worry about, Think Again
Website: http://www.mdpi.com/si/jpm/untold_stories/
Guest Editors: Dr. Felix W. Frueh
Deadline for manuscript submissions: 31 August 2012

You may send your manuscript now or up until the deadline.
Submitted papers should not have been published previously, nor be under
consideration for publication elsewhere. We also encourage authors to send
us their tentative title and short abstract by e-mail for approval to the
Editorial Office at jpm@mdpi.com.

This Special Issue will be fully open access. Open access (unlimited and
free access by readers) increases publicity and promotes more frequent
citations as indicated by several studies. Open access is supported by the
authors and their institutes. More information is available at
http://www.mdpi.com/about/openaccess/.

Article Processing Charges (APC) are waived for well prepared
manuscripts. However, a fee of 250 CHF will apply if extensive
English corrections must be done by the editors. For details see:
http://www.mdpi.com/about/apc/.

Please visit the Instructions for Authors before submitting a manuscript:
http://www.mdpi.com/journal/jpm/instructions/. Manuscripts should be
submitted through the online manuscript submission and editorial system at
http://www.mdpi.com/user/manuscripts/upload/.

JPM is a new international, open access journal aimed at bringing all
aspects of personalized medicine to one platform. JPM publishes cutting
edge, innovative preclinical and translational scientific research and
technologies related to personalized medicine (e.g., pharmacogenomics/
proteomics, systems biology). JPM recognizes that personalized medicine -
the assessment of genetic, environmental and host factors that cause
variability of individuals - is a challenging, transdisciplinary topic that
requires discussions from a range of experts. For a comprehensive
perspective of personalized medicine, JPM aims to integrate expertise
from the molecular and translational sciences, therapeutics and diagnostics,
as well as discussions of regulatory, social, ethical and policy aspects.
We provide a forum to bring together academic and clinical researchers,
biotechnology, diagnostic and pharmaceutical companies, health
professionals, regulatory and ethical experts, and government and
regulatory authorities.

MDPI publishes several peer-reviewed, open access journals listed at
http://www.mdpi.com/. The Editorial Board members, including several
Nobel Laureates (http://www.mdpi.com/about/nobelists/), are all leading
active scholars. All MDPI journals maintain rapid, yet rigorous, peer-
review, manuscript handling and editorial processes. MDPI journals have
increased their impact factors, see "2010 Newly Released Impact Factors",
http://www.mdpi.com/about/announcements/121/.

In case of questions, please contact the Editorial Office at:
jpm@mdpi.com

We are looking forward to hearing from you.

Kind regards,
MDPI AG

On behalf of the Guest Editor

Dr. Felix W. Frueh
R&D, Personalized Medicine
Medco Health Solutions, Inc.
USA
Website: http://www.medcoresearchinstitute.com
E-Mail: felix_frueh@medco.com

--
MDPI AG
Kandererstrasse 25,
CH-4057 Basel, Switzerland
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
E-Mail: jpm@mdpi.com
http://www.mdpi.com/